About this trial
Psychological distress is a multi-factorial experience of a psychological, social, spiritual, and/or physical nature that may interfere with one's ability to cope effectively with cancer, physical symptoms and treatment. Psychological distress is common and affects the efficacy and prognosis of patients with lung cancer. The systematic anti-tumor therapy may effectively relieve psychological distress including anxiety, depression, and fatigue in patients with advanced lung cancer, the relief of the psychological distress can in turn improve the therapeutic effect.
In summary, this study is to explore the associations of (dynamic) psychological stress with the efficacy and survival of anti-tumor therapy including immunotherapy and targeted therapy for advanced lung cancer patients.
Eligibility criteria
Qualifiers
Histologically proven diagnosis of lung cancer
18 years of age or older
Ability to understand and the willingness to sign a written informed consent document
Disqualifiers
Not willing to participate in this clinical trial
Trial design
Treatments tested in this trial
- immunotherapy
- Targeted Therapy Agent